In January, pharmaceutical giant Bristol-Myers Squibb bought Alpharetta drug developer Inhibitex for $2.5 billion.
dmarkiewicz@ajc.com, Atlanta Journal-Constitution: Business
Sun, 06/17/2012 - 6:39am
In January, pharmaceutical giant Bristol-Myers Squibb bought Alpharetta drug developer Inhibitex for $2.5 billion.